OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
3.930
+0.040 (1.03%)
Jan 23, 2025, 12:23 PM EST - Market open
OraSure Technologies Revenue
OraSure Technologies had revenue of $39.92M in the quarter ending September 30, 2024, a decrease of -55.25%. This brings the company's revenue in the last twelve months to $224.26M, down -50.46% year-over-year. In the year 2023, OraSure Technologies had annual revenue of $405.47M with 4.64% growth.
Revenue (ttm)
$224.26M
Revenue Growth
-50.46%
P/S Ratio
1.29
Revenue / Employee
$351,509
Employees
638
Market Cap
293.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 405.47M | 17.99M | 4.64% |
Dec 31, 2022 | 387.48M | 153.81M | 65.82% |
Dec 31, 2021 | 233.67M | 61.95M | 36.08% |
Dec 31, 2020 | 171.72M | 17.12M | 11.07% |
Dec 31, 2019 | 154.61M | -27.14M | -14.93% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
OSUR News
- 10 days ago - NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims - Business Wire
- 15 days ago - OraSure to Present at the J.P Morgan Healthcare Conference - GlobeNewsWire
- 16 days ago - CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewsWire
- 16 days ago - OraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewsWire
- 4 weeks ago - OraSure Technologies Acquires Sherlock Biosciences - GlobeNewsWire
- 6 weeks ago - OraSure Technologies: Discounted Assets With An Attractive Free Call Option - Seeking Alpha
- 7 weeks ago - OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test - GlobeNewsWire
- 2 months ago - OraSure to Participate in Upcoming Investor Conference - GlobeNewsWire